Bruce C. Cozadd
Co-Founder & ChairmanMr. Bruce C. Cozadd serves as an Independent Director of Acelyrin, Inc. since March 7, 2022 and also serves as its Chairman of Board since January 2023. He served as Member of Board of Advisors at Cellares Corp. until 2022. He co-founded Jazz Pharmaceuticals Public Limited Company in 2003 and has been its Chairman since April 2009 and served as its Chief Executive Officer since April 2009 until August 11, 2025 and served as its Interim Principal Financial Officer from October 2019 to March 2020. Mr. Cozadd serves as the Chairman and Chief Executive Officer at Azur Pharma Limited. He has extensive experience across all aspects of biopharmaceutical company build, including research and development, manufacturing, finance, corporate planning and sales and marketing. He served in various executive management positions with ALZA Corporation from 1991 to 2001, including Vice President of Corporate Planning and Analysis. He served as Executive Vice President and Chief Operating Officer at ALZA Corporation from January 2000 to 2001. From 1991 until 2001, he held various positions with ALZA Corporation, a pharmaceutical company acquired by Johnson & Johnson, most recently as Executive Vice President and Chief Operating Officer, with responsibility for research and development, manufacturing and sales and marketing. He served as Senior Vice President of ALZA from 1997 to 1999, Chief Financial Officer from 1994 to 1999 and Vice President from 1994 to 1996. Mr. Cozadd served as Executive Chairman at Jazz Pharmaceuticals plc from 2003 to 2009. He served as an Independent Director of Cerus Corporation since November 2001 until January 3, 2018. Mr. Cozadd has been a Director of Jazz Pharmaceuticals Public Limited Company since 2003, Threshold Pharmaceuticals Inc. since December 27, 2005 to August 2017 and Danisco US Inc. (formerly DuPont Industrial Biosciences) since 2000. He serves as a Director of EKOS Corporation. He serves as Board Emeritus of TheatreWorks Inc. He serves on the boards of Stanford Hospital and Clinics and the Stanford Molecular Imaging Advisory Board. He serves on the boards of two non-profit organizations, The Nueva School and SFJAZZ. Mr. Cozadd is a member of the board of Biotechnology Innovation Organization (BIO), where he serves on the Health Section Governing Board. He served as a Member of the Health Care Investment Banking team at Smith Barney, Harris Upham & Co. Mr. Cozadd received an MBA from the Stanford Graduate School of Business and a BS in Molecular Biophysics and Biochemistry and Economics from Yale University.
Positions
- Company NameJazz Pharmaceuticals plcStock CodeJAZZPositionCo-Founder & ChairmanColleagues
- RDRenee D. GalaPresident, CEO & Director
- PLPhilip L. JohnsonExecutive VP & CFO
- NMNeena M. PatilExecutive VP & Chief Legal Officer
- RIRobert IannoneExecutive VP, Chief Medical Officer and Global Head of Research & Development
- HAHeather Ann McSharryIndependent Director
- JEJennifer E. CookIndependent Non-Executive Director
- PTPatrick T. KennedyIndependent Director
